Oligoprogressive Oncogene-addicted Lung Tumours: Does Stereotactic Body Radiotherapy Have a Role? Introducing the HALT Trial. (2018)
Attributed to:
Molecular insights into ubiquitin remodelling factor p97(VCP) in DNA damage response and genome stability
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.clon.2017.10.013
PubMed Identifier: 29153859
Publication URI: http://europepmc.org/abstract/MED/29153859
Type: Journal Article/Review
Volume: 30
Parent Publication: Clinical oncology (Royal College of Radiologists (Great Britain))
Issue: 1
ISSN: 0936-6555